Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like Colorado State University And Synaptive Medical Collaborate To Better Detect Brain Tumors May 23, 2017 How Roche Fine-Tuned an Old Drug Under a New Name to Keep Making Profits August 23, 2017 3 Biotechs With Critical Product Launches in 2018 December 10, 2017
Colorado State University And Synaptive Medical Collaborate To Better Detect Brain Tumors May 23, 2017
